we assessed the long-term outcome ( 2 1/2- to 3-year follow-up ) in patients with parkinson 's disease who participated in our previous pergolide double-blind trial and were subsequently switched to open-label pergolide therapy .
C0030567
parkinson 's disease
C0031007
pergolide